|
Between 25,000 and 75,000 new cases of angina refractory to maximal medical therapy and standard coronary revascularization procedures are diagnosed each year. Heart failure places an enormous burden on the health care system.
In recent years, improvements in both pharmacologic and revascularization therapies have greatly increased life expectancy for patients with coronary artery disease (CAD). As patients with more extensive CAD live longer, many develop myocardial ischemia and clinical angina that is not amenable to traditional revascularization therapy. Patients with severe, symptomatic, chronic CAD have been described as having refractory angina; they have also been termed "no-option" patients. Enhanced external counterpulsation - EECP is an emerging option in this unique and growing group of patients.
Dr. Ashok Punjabi - EECP Cardiology Specialist in mumbai:
The following are few interviews given by him for various News Channels on EECP - Enhanced External CounterPulsation.
|
|
